Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Stephanie Theresa Jünger"'
Publikováno v:
Child's Nervous System
Pediatric ependymomas comprise biologically distinct tumor entities with different (epi)genetics, age distribution and localization, as well as a different prognosis. Regarding risk stratification within these biologically defined entities, histopath
Autor:
Clemens Sommer, Thomas Rüdiger, Jörg Faber, Verena Dreschmann, Stéphanie Puget, Bernhard Erdlenbruch, B Bernbeck, Evelyn Dörner, Dominik T. Schneider, Sung Hye Park, Alexandra Russo, Felipe Andreiuolo, Selim Corbacioglu, Martina Messing-Jünger, Torsten Pietsch, Stephanie Theresa Jünger, Marco Prinz, Markus J. Riemenschneider, Markus Bergmann, Andreas Waha, Irene Slavc, Christine Haberler, Rupert Handgretinger, Miriam van Buiren, Antonia Jakovcevic, Sven Armbrust, Alfred Leipold, Harald Reinhard, Arnault Tauziède-Espariat, Dieter Körholz, Klaus Kuchelmeister, Martina Rose, Johann Lorenzen, Martin Ebinger, Manuela Neumann, Jelena Roganović, Pascale Varlet, Till Acker, Elke Hattingen, Volkmar Hans, Jacques Grill
Publikováno v:
Brain Pathology. 29:205-216
Ependymoma with YAP1-MAMLD1 fusion is a rare, recently described supratentorial neoplasm of childhood, with few cases published so far. We report on 15 pediatric patients with ependymomas carrying YAP1-MAMLD1 fusions, with their characteristic histop
Autor:
Carolin Seidel, Torsten Pietsch, Annika Hohm, Monika Warmuth-Metz, Katja von Hoff, Henner Huflage, Johannes Nowak, Stephanie Theresa Jünger, Stefan Rutkowski, Lindsey A. Vandergrift
Publikováno v:
Clinical Neuroradiology. 29:595-604
Epigenetic profiling has recently identified clinically and molecularly distinct subgroups of ependymoma. The 2016 World Health Organization (WHO) classification recognized supratentorial ependymomas (ST-EPN) with REL-associated protein/p65 (RELA) fu
Autor:
Anja zur Mühlen, Martin Mynarek, André O. von Bueren, Felipe Andreiuolo, Torsten Pietsch, Stefan Rutkowski, Evelyn Dörner, Stephanie Theresa Jünger
Young age represents an adverse prognostic factor in children with ependymomas. Their treatment is challenging since beneficial therapeutic options are limited. As ependymomas are considered a biologically heterogeneous group we aimed to characterize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2920b6b93a79da65f82b11e356f3f51
https://europepmc.org/articles/PMC6477193/
https://europepmc.org/articles/PMC6477193/
Autor:
Beate Timmermann, Stefan Rutkowski, Torsten Pietsch, Katja von Hoff, Natalia Velez-Char, Felipe Andreiuolo, Anja zur Mühlen, Rolf-Dieter Kortmann, Evelyn Dörner, André O. von Bueren, Martin Mynarek, Stephanie Theresa Jünger, Monika Warmuth-Metz
Publikováno v:
Neuro-Oncology
INTRODUCTION Since supratentorial RELA-fusion positive ependymomas are considered a biologically distinct disease, we aimed to identify histological and genetic predictors of outcome in a defined cohort of pediatric patients. MATERIALS AND METHODS We
Autor:
Stephanie Theresa Jünger, Didier Scavarda, François Labrousse, Catherine Godfraind, Henri Sevestre, Philippe Metellus, Anne Jouvet, Carole Colin, Isabelle Quintin-Roue, Corinne Bouvier, Emeline Tabouret, Marie-Christine Machet, Felipe Andreiuolo, Emmanuèle Lechapt-Zalcman, Fabien Forest, André Maues De Paula, Anne Heitzmann, Torsten Pietsch, Serge Milin, Dominique Figarella-Branger
Publikováno v:
Neuro-Oncology
Neuro-Oncology, Oxford University Press (OUP), 2016, 18, pp.919-927. ⟨10.1093/neuonc/now025⟩
Neuro-Oncology, 2016, 18, pp.919-927. ⟨10.1093/neuonc/now025⟩
Neuro-Oncology, Oxford University Press (OUP), 2016, 18, pp.919-927. ⟨10.1093/neuonc/now025⟩
Neuro-Oncology, 2016, 18, pp.919-927. ⟨10.1093/neuonc/now025⟩
International audience; Clear cell ependymoma is one of the 4 main histological subtypes of ependymomas defined by the World Health Organization (WHO) classification of tumors of the CNS. DNA methylation profiling can distinguish 4 subgroups of in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01de6fda86ecc21205375648454664b9
https://europepmc.org/articles/PMC4896549/
https://europepmc.org/articles/PMC4896549/